ScholarMate
English简体中文繁體中文
客服热线:400-1616-289
登录注册
期刊论文

Amiloride off-target effect inhibits podocyte urokinase receptor expression and reduces proteinuria

Zhang Bin; Xie Shaoting; Shi Wei*; Yang Yun广东省人民医院
Nephrology Dialysis Transplantation2012-5DOI: 10.1093/ndt/gfr612
21被引2阅读
引用收藏
分享

摘要

The urokinase receptor (uPAR) and its soluble form play a key role in the pathogenesis of focal segmental glomerulosclerosis (FSGS). The modification of uPAR pathological actions on podocytes will become an important task for the development of improved nephroprotective therapeutics. Here we show that podocyte uPAR expression can be reduced using amiloride. Amiloride has a significant role in the reduction of podocyte cell motility in vitro and proteinuria in mice. Amiloride inhibited the induction of uPAR protein and PLAUR messenger RNA (encoding uPAR) and with that it reduced uPAR-mediated beta 3 integrin activation in lipopolysaccharide (LPS)-treated podocytes. Transwell migration assay and wound healing assay showed that directed and random podocyte motility of LPS-treated podocytes were increased and substantially reduced by amiloride. The off-target effect of amiloride was independent of its function as epithelial sodium channel blocker and different from triamterene. Amiloride was also effective in the LPS mouse model of transient proteinuria (LPS mice) and in the 5/6 nephrectomy rat FSGS model (NTX) by significantly inhibiting podocyte uPAR induction, reducing proteinuria. In addition, amiloride attenuated glomerulosclerosis, as determined by glomerulosclerotic index. Thus, our observations show that amiloride inhibits podocyte uPAR induction and reduces proteinuria in NTX rats and LPS mice. Given the pathological relevance of the uPAR-beta 3 integrin signaling axis in FSGS, amiloride may be utilized in patients with FSGS.

学科与关键词

关键词
amiloridebeta 3 integrinpodocyteproteinuriaurokinase receptor
相关
加载中…
  • 1,25-Dihydroxyvitamin D(3) Inhibits Podocyte uPAR Expression and Reduces Proteinuria
    Ma Jianchao; Zhang Bin; Liu Shuangxin; Xie Shaoting; Yang Yun; Ma Juan; Deng Yujun; Wang Wenjian; Xu Lixia; Li Ruizhao; Zhang Li; Yu Chunping; Shi Wei*PLoS ONE, 2013, 8(5): e64912.被引 1
  • The calcineurin-NFAT pathway allows for urokinase receptor-mediated beta3 integrin signaling to cause podocyte injury
    Zhang Bin; Shi Wei*; Ma Juan; Sloan Alexis; Faul Christian; Wei Changli; Reiser Jochen; Yang Yun; Liu Shuangxin; Wang WenjianJournal of Molecular Medicine, 2012, 90(12): 1407-1420.被引 18
  • The effect of amiloride in decreasing albuminuria in patients with diabetic kidney diseases: a prospective, crossover, open-label study
    Li, Ruizhao; Xie, Zhiyong; Zhang, Li; Huang, Ying; Ma, Jianchao; Dong, Wei; Li, Zhilian; Chen, Yuanhan; Liang, Huaban; Wu, Yanhua; Zhao, Xingchen; Wang, Wenjian; Ye, Zhiming; Liu, Shuangxin; Shi, Wei; Liang, Xinling*RENAL FAILURE, 2021, 43(1): 452-459.被引 2
查看全部 →

发表信息

论文状态
公开发表
期刊
Nephrology Dialysis Transplantation
发表日期
2012-05
卷期
第 27 卷, 第 5 期
页码
1746-1755
DOI
10.1093/ndt/gfr612
语言
ENGLISH
成果收录
SCI
资助标注
Guangdong Science and Technology Department

作者

  • Z

    Zhang Bin (第一作者)

    guangdong gen hosp · so med univ

  • X

    Xie Shaoting

    guangdong gen hosp · so med univ

查看全部 4 位作者收起作者
  • S

    Shi Wei (通讯)

    guangdong gen hosp

  • Y

    Yang Yun

    guangdong gen hosp

登录解锁更多功能

  • 收藏这篇,随时在“我的 · 收藏”找回
  • 认领你的成果,生成推广素材
  • 关注作者获取最新成果
  • 加入项目组、协同写作
注册 / 登录

产品服务

  • 科研之友
  • 创新城
  • 科创云

服务支持

  • 帮助中心
  • 隐私政策
  • 服务条款

联系方式

在线客服:【】
客服热线:400-1616-289
电子邮箱:support@scholarmate.com

关注或下载科研之友

微信二维码
微信公众号
客户端下载二维码
下载客户端
科研成果科研人员科研机构科研动态爱瑞思软件

©2026 深圳市科研之友网络服务有限公司

公安备案图标粤公网安备 44030502000213
粤ICP备 16046710 号粤B2-20110417